Skip to content

A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand

A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05598801
Enrollment
17
Registered
2022-10-28
Start date
2022-09-01
Completion date
2025-08-17
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture Repair, Tendon Repair, Tenolysis

Brief summary

The purpose of this study is to evaluate the efficacy on the use of VersaWrap® in surgery of the hand/fingers, including tendon repair, fracture repair, or tenolysis of the hand/fingers. VersaWrap is designed to allow tendon gliding and to protect tendon gliding postoperatively

Detailed description

This is a prospective, post-market, observational, single center study evaluating the use of VersaWrap. Patients identified by the Investigator in his practice as needing surgery of the hand/fingers and meeting all the inclusion and none of the exclusion. Patients will consent to participating in the study, prior to any study procedures.

Interventions

DEVICEVersaWrap

VersaWrap is applied to the affected tendon to allow post-operative gliding.

Sponsors

Research Source
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients aged 18-70 at the time of surgery 2. Patients undergoing hand/finger surgery, including tendon repair, fracture repair or tenolysis 3. Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule, study requirements with a signed informed consent with a study collaborator present at the time of signing to ensure compliance.

Exclusion criteria

1. Non-English speaking 2. Known allergy or sensitivity to citrate, alginate or hyaluronate 3. Pregnant or breastfeeding 4. Currently a prisoner 5. Patient has any condition, that in the opinion of the Investigator, would prohibit the patient from complying with the protocol

Design outcomes

Primary

MeasureTime frame
Number of participants diagnosed with post-operative tenolysis6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026